KATIE ROBINSON: Open Payments
NPI 1225500846 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 16 payments from 10 companies in 2025. Trend: 2023 $219 · 2024 $623 · 2025 $562
Food & beverage: $509Education: $53
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 2 | $180 |
| GENZYME CORPORATION | 5 | $174 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Smith+Nephew, Inc. | 1 | $21 |
| Optinose US, Inc. | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
| Boston Scientific Corporation | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: DUPIXENT, Kerecis SurgiClose, NUCALA, OASIS, Xhance, NEFFY, WaveWriter Alpha Prime 16, TEZSPIRE.
Industry payments across AL — which companies pay providers there.
